Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?
Titel:
Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?
Auteur:
Laparra, A. Kfoury, M. Champiat, S. Danlos, F.X. Martin-Romano, P. Simonaggio, A. Baldini, C. Vuagnat, P. Mateus, C. Voisin, A.L. Albiges, L. Besse, B. Even, C. Robert, C. Laghouati, S. Massard, C. Marabelle, A. Lambotte, O. Michot, J.M.